PartnershipJul 14, 2026, 01:31 PM
Prenetics' IM8 Secures $1B Growth Financing from General Catalyst
AI Summary
Prenetics Global Limited announced that its AI-native wellness brand, IM8, has secured $1 billion in growth financing from General Catalyst's Customer Value Fund. This non-dilutive arrangement will fund up to 70% of IM8's marketing spend, allowing for accelerated growth without issuing equity. Following this, Prenetics raised its full-year 2026 IM8 revenue guidance to $210-$220 million and projects IM8 to reach $400 million or more in full-year 2027 revenue.
Key Highlights
- IM8 secured $1 billion in growth financing from General Catalyst's Customer Value Fund (CVF).
- The financing is non-dilutive, with no equity, warrants, or convertible instruments issued.
- General Catalyst will finance up to 70% of IM8's marketing spend.
- Prenetics raised full-year 2026 IM8 revenue guidance to $210-$220 million, up from $190-$210 million.
- IM8 is expected to reach $300 million in annualized run-rate revenue by year-end 2026.
- IM8 is expected to deliver $400 million or more in full-year 2027 revenue.
- Every $1 invested in customer acquisition has returned $1.44 in gross profit.
- Prenetics held approximately $139.7 million in cash and equivalents as of May 31, 2026.
Price Impact
More from PRE